- Home
- DCTH vs BBCP Comparison
DCTH vs BBCP Comparison
Compare DCTH & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- BBCP
- Stock Information
- Founded
- DCTH 1988
- BBCP 1983
- Country
- DCTH United States
- BBCP United States
- Employees
- DCTH N/A
- BBCP N/A
- Industry
- DCTH Medical/Dental Instruments
- BBCP Engineering & Construction
- Sector
- DCTH Health Care
- BBCP Consumer Discretionary
- Exchange
- DCTH Nasdaq
- BBCP Nasdaq
- Market Cap
- DCTH 394.9M
- BBCP 360.0M
- IPO Year
- DCTH N/A
- BBCP 2017
- Fundamental
- Price
- DCTH $10.96
- BBCP $6.89
- Analyst Decision
- DCTH Strong Buy
- BBCP Buy
- Analyst Count
- DCTH 4
- BBCP 2
- Target Price
- DCTH $24.00
- BBCP $7.00
- AVG Volume (30 Days)
- DCTH 710.7K
- BBCP 83.7K
- Earning Date
- DCTH 08-06-2025
- BBCP 09-03-2025
- Dividend Yield
- DCTH N/A
- BBCP N/A
- EPS Growth
- DCTH N/A
- BBCP N/A
- EPS
- DCTH N/A
- BBCP 0.23
- Revenue
- DCTH $53,850,000.00
- BBCP $401,503,000.00
- Revenue This Year
- DCTH $162.10
- BBCP N/A
- Revenue Next Year
- DCTH $32.97
- BBCP $4.28
- P/E Ratio
- DCTH N/A
- BBCP $29.79
- Revenue Growth
- DCTH 1068.87
- BBCP N/A
- 52 Week Low
- DCTH $7.17
- BBCP $4.78
- 52 Week High
- DCTH $18.23
- BBCP $9.68
- Technical
- Relative Strength Index (RSI)
- DCTH 42.66
- BBCP 53.67
- Support Level
- DCTH $10.44
- BBCP $6.61
- Resistance Level
- DCTH $11.67
- BBCP $6.95
- Average True Range (ATR)
- DCTH 0.46
- BBCP 0.21
- MACD
- DCTH 0.11
- BBCP -0.03
- Stochastic Oscillator
- DCTH 68.03
- BBCP 44.23
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.